He aha ka Rituximab-a-Hyaluronidase-Human-Recombinant-Subcutaneous-Route? Nā Hōʻailona, ​​Nā Kumu, & Lapaʻau Kūloko

ʻO ka rituximab-a-hyaluronidase-human-recombinant-subcutaneous-route he lāʻau hui e kōkua ana i ka mālama ʻana i kekahi mau maʻi koko a me nā maʻi autoimmune. Hoʻohui kēia lapaʻau i ka rituximab, kahi lāʻau lapaʻau i manaʻo ʻia no ka maʻi kanesa, me ka hyaluronidase, kahi enzyme e kōkua ana i ka laha ʻana o ka lāʻau lapaʻau ma lalo o kou ʻili ke hāʻawi ʻia ma ke ʻano he injection.

Ua hoʻolālā ʻia kēia lāʻau lapaʻau e hāʻawi ʻia ma lalo o ka ʻili ma mua o ka IV, e maʻalahi ai ka lapaʻau no nā maʻi he nui. Hana ka mea hyaluronidase e like me ke kōkua, e wāwahi ana i nā pale i loko o kou ʻiʻo i hiki i ka rituximab ke hiki i kahi e pono ai e hele ʻoi aku ka maikaʻi.

He aha ka Rituximab-a-Hyaluronidase-Human-Recombinant-Subcutaneous-Route?

ʻO kēia lāʻau lapaʻau he lāʻau lapaʻau maʻi kanesa kūikawā e hoʻohui i ʻelua mea nui i hoʻokahi injection. ʻO Rituximab kahi antibody monoclonal e kuhikuhi ana i nā protein kikoʻī ma nā cell immune, ʻoiai ʻo hyaluronidase kahi enzyme e kōkua ana i nā lāʻau lapaʻau e laha maʻalahi ma o ka ʻiʻo.

Hana ka lapaʻau ma ka manaʻo ʻana i nā protein CD20 i loaʻa ma nā B-cell, he ʻano o ke keʻokeʻo koko. Ke lilo kēia mau cell i mea maʻi a i ʻole ka hana nui ʻana i nā maʻi autoimmune, kōkua ka rituximab i kāu ʻōnaehana pale e ʻike a luku iā lākou.

ʻO ke ala subcutaneous ʻo ia ka hoʻokomo ʻia ʻana o ka lāʻau lapaʻau ma lalo o kou ʻili, e like me ke ʻano o ka hāʻawi ʻia ʻana o nā lāʻau lapaʻau diabetes. Hāʻawi kēia ala i kahi koho ʻoi aku ka maʻalahi i nā infusions IV kuʻuna e hiki ke lawe i kekahi mau hola i loko o kahi keʻena lapaʻau.

Pehea ke ʻano o ka Rituximab-a-Hyaluronidase-Human-Recombinant-Subcutaneous-Route?

ʻO ka injection ponoʻī e like me ka ʻeha pōkole a i ʻole ke kuʻi ʻana, e like me ka loaʻa ʻana o ka lāʻau lapaʻau. He liʻiliʻi ka nila i hoʻohana ʻia, a ʻo ka injection e lawe maʻamau i kekahi mau minuke e hoʻopau.

I ka wā o ka pahu ʻana, e ʻike paha ʻoe i ke kaomi a i ʻole ka ʻoluʻolu ma kahi o ka pahu ʻana. Hōʻike kekahi poʻe maʻi i ka manaʻo wela iki e mau ana no kekahi mau kekona i ka wā e komo ai ka lāʻau lapaʻau i loko o ka ʻiʻo ma lalo o kou ʻili.

Ma hope o ka pahu ʻana, e ʻoluʻolu paha ka wahi a i ʻole e pehu iki no hoʻokahi a ʻelua paha lā. He mea maʻamau kēia a hōʻike i ka hana ʻana o ka hyaluronidase e kōkua i ka laha pono ʻana o ka rituximab ma o kou ʻiʻo.

He aha ke kumu o ka pono no Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route?

Hoʻopaʻa ʻia kēia lāʻau lapaʻau ke loaʻa iā ʻoe kekahi mau maʻi kahi e hana ai kāu mau pūnaewele B i nā pilikia i loko o kou kino. ʻO nā kumu maʻamau e pili ana i nā ʻano maʻi koko a me nā maʻi autoimmune kahi i lilo ai kēia mau pūnaewele i mea hana nui a i ʻole malignant.

E ʻōlelo aku kāu kauka i kēia lapaʻau ma muli o kekahi mau mea e lilo ai ʻoe i mea kūpono no ka hāʻawi ʻana i ka subcutaneous. Kōkua kēia mau mea e hoʻoholo inā e palekana a maikaʻi hoʻi kēia ala no kāu maʻi kikoʻī.

ʻO ka hoʻoholo e hoʻohana i ke ʻano subcutaneous e pili pinepine i ka maʻalahi a me kou hiki ke ʻae i ka lapaʻau. Makemake kekahi poʻe maʻi i kēia koho no ka mea hiki ke hāʻawi ʻia me ka wikiwiki a ʻaʻole pono i ke kaʻina hana IV infusion lōʻihi.

He aha ka Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route he hōʻailona a hōʻailona paha o?

ʻAʻole he hōʻailona kēia lāʻau lapaʻau akā he lapaʻau no nā maʻi maʻi. ʻO ka pono no kēia lāʻau lapaʻau e hōʻike ana ua ʻike ʻia ʻoe me kekahi mau ʻano o ka lymphoma non-Hodgkin a i ʻole ka leukemia lymphocytic maʻi.

Hiki i kāu hui mālama ola ke kauoha i kēia lapaʻau no kekahi mau maʻi autoimmune kahi e hoʻouka ai nā pūnaewele B i ka ʻiʻo olakino i loko o kou kino. Hiki i kēia mau maʻi ke komo i ka rheumatoid arthritis, kekahi mau ʻano o ka vasculitis, a i ʻole nā ​​maʻi ʻōnaehana pale.

Hōʻike pinepine ka koho kikoʻī o ke ala subcutaneous i ka loiloi a kāu kauka ua paʻa ʻoe no kēia ʻano lapaʻau maʻalahi. Hōʻike pū kekahi ia ua pane maikaʻi kou maʻi i ka lāʻau rituximab i ka wā ma mua.

Hiki i nā hopena ʻaoʻao mai Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route ke hele wale aku?

He nui nā hopena ʻaoʻao maʻalahi mai kēia lapaʻau e hoʻoponopono wale ʻia i loko o kekahi mau lā a i ʻole mau pule. ʻO nā hopena maʻamau e like me ka ʻulaʻula ʻana o ka pūnaewele injection, ka pehu ʻana, a i ʻole ke aloha e hoʻomaikaʻi maʻamau i loko o 24 a 48 mau hola me ka ʻole o ka lapaʻau kūikawā.

ʻO kekahi mau hopena ʻōnaehana, e like me ka luhi maʻalahi a i ʻole ke kuni haʻahaʻa, e mae pinepine ana i ka wā e hoʻoponopono ai kou kino i ka lāʻau i nā pōʻai lapaʻau mua. E aʻo mālie ana kāu ʻōnaehana pale e ʻae maikaʻi i ka lapaʻau me kēlā me kēia mahele.

Eia naʻe, he mea nui e hoʻomanaʻo i nā hopena ʻaoʻao koʻikoʻi e pono ai ka lāʻau lapaʻau a ʻaʻole e hoʻoponopono wale ʻia. E nānā pono kāu hui mālama ola iā ʻoe e hoʻokaʻawale ma waena o nā hopena maʻamau, manawa pōkole a me nā mea e pono ai ke komo.

Pehea e hiki ai ke mālama ʻia nā hopena ʻaoʻao mai Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route ma ka home?

No nā hopena maʻalahi o ka pūnaewele injection, hiki iā ʻoe ke hoʻopili i kahi compress anuanu i ka wahi no 10 a 15 mau minuke i ka manawa e hōʻemi ai i ka pehu a me ka ʻoluʻolu ʻole. E pale i ka hoʻopili ʻana i ka hau pololei i kou ʻili, a mai hoʻohana i ka compress no nā minuke ma mua o 20 i ka manawa.

Inā ʻike ʻoe i ka luhi maʻalahi, hiki i ka hoʻomaha kūpono a me ka noho ʻana i ka wai ke kōkua i kou kino e ola wikiwiki. ʻO nā hana māmā e like me ka hele mālie e kōkua iā ʻoe e ʻoi aku ka ikaika ma mua o ka hoʻomaha moe piha.

Hiki i nā mea hōʻoluʻolu ʻeha ma luna o ka pāʻani e like me ka acetaminophen ke kōkua i ka mālama ʻana i ka ʻoluʻolu maʻalahi, akā e nānā mau me kāu hui mālama ola ma mua o ka lawe ʻana i nā lāʻau lapaʻau hou. Pono lākou e hōʻoia ʻaʻole e keakea kekahi mea i kāu lapaʻau a i ʻole e hūnā i nā hōʻailona koʻikoʻi.

E mālama i ka wahi i hoʻokomo ʻia i ka lāʻau lapaʻau i maʻemaʻe a maloʻo, a e pale i ka hamo ʻana a i ʻole ka lomilomi ʻana i ka wahi no nā hola 24 mua. Hiki i nā lole ʻoluʻolu a ākea ke kōkua i ka pale ʻana i ka huhū i ka wā e ola ai ka wahi.

He aha ka lāʻau lapaʻau no nā hopena ʻaoʻao koʻikoʻi o Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route?

E loaʻa i kāu hui mālama ola nā protocols kikoʻī e mālama ai i nā hopena koʻikoʻi e hiki ke hana. No nā hopena maʻi maʻi koʻikoʻi, hiki iā lākou ke hoʻohana i nā antihistamines, corticosteroids, a i ʻole epinephrine ma muli o ke koʻikoʻi o kāu mau hōʻailona.

Inā ʻoe e hoʻomohala i nā hōʻailona o ka maʻi lysis tumor, kahi e wāwahi koke ai nā sela maʻi maʻi, hiki i kāu kauka ke hāʻawi i nā wai IV a me nā lāʻau lapaʻau e pale i kou mau puʻupaʻa a me ke kaulike ʻana i kāu electrolytes. ʻOi aku ka maʻamau o kēia i nā maʻi me ka nui o ka maʻi maʻi i loko o ko lākou kino.

No nā maʻi e hiki ke hoʻomohala ʻia ma muli o nā hopena o ka lāʻau lapaʻau i kāu ʻōnaehana pale, e kauoha kāu kauka i nā antibiotics kūpono, antifungals, a i ʻole nā lāʻau antiviral. Hiki iā lākou ke hoʻomaha i kāu lapaʻau a hiki i ka pau ʻana o ka maʻi.

I nā hihia o nā hopena ʻili koʻikoʻi a i ʻole ka leukoencephalopathy multifocal progressive (he maʻi lolo kakaʻikahi akā koʻikoʻi), pono paha e hoʻololi a hoʻōki paha i kāu hoʻolālā lapaʻau. E hana pili kāu hui lapaʻau me nā loea e hāʻawi i ka mālama maikaʻi loa.

I ka manawa hea wau e ʻike ai i ke kauka no nā hopohopo e pili ana iā Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route?

Pono ʻoe e hoʻokaʻaʻike koke i kāu hui mālama ola inā ʻoe e hoʻomohala i nā hōʻailona o kahi hopena maʻi maʻi koʻikoʻi, e like me ka pilikia o ka hanu ʻana, ka ʻūhū ākea, a i ʻole ka pehu ʻana o kou maka, nā lehelehe, a i ʻole ka ʻāʻī. Hiki i kēia mau hōʻailona ke hoʻomohala wikiwiki a koi i ka lāʻau lapaʻau koke.

E kelepona koke i kāu kauka inā ʻike ʻoe i nā hōʻailona o ka maʻi, e like me ke kuni ma luna o 100.4°F (38°C), nā anu, ka ʻū mau, a i ʻole ka luhi ʻole. Hiki ke nāwaliwali kou ʻōnaehana pale no kekahi manawa, e hoʻolilo ana i nā maʻi i ʻoi aku ka koʻikoʻi ma mua o ka maʻamau.

E launa aku i kāu hui lapaʻau inā ʻike ʻoe i nā hopena koʻikoʻi a i ʻole e ʻino ana i ka pūnaewele injection, e like me ka hoʻonui ʻana i ka ʻulaʻula e laha ana ma waho o ka wahi injection, ka mahana, a i ʻole ka hoʻokahe ʻana e like me ka pus. Hiki i kēia mau mea ke hōʻike i kahi maʻi kūloko e pono ai ka mālama ʻana.

Pono nō hoʻi ʻoe e ʻimi i ka lāʻau lapaʻau no nā hōʻailona neurological e like me ka huikau, nā loli ʻike, ka pilikia o ka ʻōlelo ʻana, a i ʻole ka nāwaliwali ma kekahi ʻaoʻao o kou kino. ʻOiai he mea maʻamau, hiki i kēia mau mea ke hōʻike i nā pilikia koʻikoʻi e pono ai ka loiloi koke.

He aha nā mea pilikia no ka hoʻomohala ʻana i nā hopena ʻaoʻao koʻikoʻi mai Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route?

ʻO ka loaʻa ʻana o ka mōʻaukala o ka maʻi hepatitis B a i ʻole C e hoʻonui i kou pilikia o kēia mau maʻi e hoʻāla hou i ka wā o ka mālama ʻana. E hoʻāʻo kāu kauka no kēia mau maʻi ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau a e nānā pono iā ʻoe i ka wā o ka mālama ʻana.

ʻO nā maʻi me nā ʻōnaehana pale i hoʻopilikia ʻia mai nā kūlana ʻē aʻe a i ʻole nā lāʻau lapaʻau e kū ana i nā pilikia kiʻekiʻe o ka hoʻomohala ʻana i nā maʻi koʻikoʻi. Pākuʻi ʻia kēia i nā poʻe e lawe ana i nā lāʻau immunosuppressive ʻē aʻe a i ʻole nā poʻe me nā kūlana e like me ka HIV.

Hiki i ka makahiki ke lilo i mea, no ka mea, ʻoi aku ka maʻalahi o nā mākua kahiko i kekahi mau hopena ʻaoʻao a hiki ke lōʻihi ka hoʻōla ʻana mai nā pilikia e pili ana i ka mālama ʻana. E hoʻoponopono kāu hui mālama ola i ka nānā ʻana a me ke kākoʻo.

ʻO ka loaʻa ʻana o ka nui o ka maʻi maʻi i loko o kou kino (kiʻekiʻe ka ukana tumor) e hoʻonui i ka pilikia o ka maʻi lysis tumor i ka wā e hoʻomaka ai ka mālama ʻana e hana wikiwiki. E hana kāu kauka i nā hana pale inā ʻoe i ka pilikia nui no kēia pilikia.

He aha nā pilikia hiki ke loaʻa o Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route?

ʻO ka pilikia koʻikoʻi loa akā kakaʻikahi, ʻo ia ka progressive multifocal leukoencephalopathy (PML), he maʻi lolo e hiki ke hoʻopōʻino mau i nā aʻalolo. Hiki kēia ke lilo kahi maʻi maʻi hiamoe i mea ikaika ma muli o ka hopena o ka lāʻau lapaʻau i kāu ʻōnaehana pale.

Hiki ke ulu nā maʻi koʻikoʻi no ka mea e hoʻemi ana ka lāʻau lapaʻau i ka hiki o kou kino ke pale aku i ka bacteria, nā maʻi, a me nā fungi. Hiki ke ʻoi aku ka koʻikoʻi o kēia mau maʻi ma mua o ka maʻamau a pono paha ka haukapila no ka mālama ʻana.

Hiki ke hana ʻia ka maʻi lysis tumor ke wāwahi koke nā pūnaewele maʻi, e hoʻokuʻu ana i kā lākou mea i loko o kou kahe koko. Hiki i kēia ke hoʻopilikia i kou mau puʻupaʻa a me ka puʻuwai, akā hana kāu hui lapaʻau i nā hana e pale a mālama i kēia pilikia.

ʻO ka neutropenia i hoʻomaka lohi, kahi e hāʻule ai ka helu o nā keʻokeʻo koko i nā mahina ma hope o ka mālama ʻana, hiki ke waiho iā ʻoe i ka maʻi. E nānā mau kāu kauka i kāu helu koko e hopu i kēia ma mua inā e hana ia.

Ua hōʻike ʻia nā hihia kakaʻikahi o nā hopena ʻili koʻikoʻi, me ka maʻi Stevens-Johnson. Pono kēia mau mea i ka lāʻau lapaʻau koke a hiki ke hopena i ka pōʻino mau o ka ʻili inā ʻaʻole i mālama koke ʻia.

He maikaʻi a ʻino paha ka Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route no ka mālama ʻana i ka maʻi maʻi?

Manaʻo ʻia kēia lāʻau lapaʻau he lāʻau lapaʻau maikaʻi loa no nā ʻano maʻi maʻi kikoʻī i hoʻolālā ʻia e kuhikuhi. Ua hōʻike nā haʻawina lapaʻau hiki iā ia ke hoʻomaikaʻi nui i nā hopena no nā maʻi me kekahi mau lymphomas B-cell a me leukemias.

Hāʻawi ke ʻano subcutaneous i nā mea maikaʻi i ka maʻalahi a me ka hōʻoluʻolu o ka mea maʻi. Nui nā maʻi e makemake i ka manawa injection pōkole ma mua o nā infusions IV lōʻihi, a hiki ke hāʻawi pinepine ʻia i nā wahi outpatient me ka liʻiliʻi o ka manawa.

Hana ka lapaʻau ma ka pahuhopu ʻana i nā pūnaewele maʻi ʻaʻai me ka waiho ʻana i ka hapa nui o nā pūnaewele olakino wale nō, ʻo ia ka mea e hopena ai i nā hopena ʻaoʻao liʻiliʻi ma mua o ka chemotherapy kuʻuna. Hiki i kēia ala i pahuhopu ʻia ke kōkua nui i nā maʻi i hiki ʻole ke ʻae i nā lapaʻau ʻoi aku ka ikaika.

Eia naʻe, e like me nā lapaʻau maʻi ʻaʻai a pau, ʻaʻole kūpono ia no kēlā me kēia maʻi a i ʻole kēlā me kēia ʻano maʻi ʻaʻai. E hoʻoholo kāu oncologist inā ʻo kēia formulation kikoʻī ka koho maikaʻi loa e pili ana i kāu hōʻailona kikoʻī a me ke kūlana olakino holoʻokoʻa.

He aha nā hopena i ka Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route i hiki ke kuhi hewa ʻia?

Hiki ke kuhi hewa ʻia nā hopena o ka pūnaewele injection no kahi maʻi ʻili maʻalahi a i ʻole ka hopena maʻi i kekahi mea ʻē aʻe. ʻO ka ʻokoʻa nui, ʻo ia ka mea e hana pinepine ai kēia mau hopena i loko o nā hola o kāu injection a hoʻomaikaʻi mālie i nā lā 1-2.

Hiki ke huikau nā hōʻailona e like me ka maʻi flu i kekahi manawa ma hope o ka lapaʻau ʻana me kahi maʻi viral maoli. Eia naʻe, hoʻomaka pinepine nā hōʻailona e pili ana i ka lapaʻau i loko o 24 mau hola o kāu injection a ʻaʻole maʻamau i nā hōʻailona hanu e like me ka ihu kahe a i ʻole ka ʻāʻī ʻeha.

Hiki ke pili ka luhi mai ka lāʻau lapaʻau i kāu maʻi ʻaʻai a i ʻole nā ​​mea kaumaha ʻē aʻe o ke ola. ʻO ka ʻokoʻa, ʻo ka luhi e pili ana i ka lapaʻau e pili pinepine ana i kahi ʻano e pili ana i kāu papa hana injection a hiki ke hoʻomaikaʻi ma waena o nā mahele.

Kuhi hewa kekahi mau maʻi i ka immunosuppression manawa no ka manaʻo maʻamau ʻole ma muli o kā lākou maʻi ʻaʻai. He mea nui e hōʻike i nā hōʻailona hou i kāu hui mālama ola i hiki iā lākou ke hoʻoholo i ke kumu a hāʻawi i ka mālama kūpono.

Nā nīnau i nīnau pinepine ʻia e pili ana i ka Rituximab-and-Hyaluronidase-Human-Recombinant-Subcutaneous-Route

Q1: Pehea ka lōʻihi o kēlā me kēia injection?

He mau minuke 5-7 ka lōʻihi o ka hoʻokomo ʻana. Akā, pono ʻoe e noho i loko o ka hale lapaʻau no ka nānā ʻana no kahi o 15 mau minuke ma hope o kāu mahele mua, a he manawa nānā pōkole paha no nā mahele ma hope. Kōkua kēia manawa nānā e hōʻoia ʻaʻole ʻoe e loaʻa i nā hopena maʻi koke.

Q2: Hiki iaʻu ke kalaiwa iaʻu iho i ka home ma hope o ka hoʻokomo ʻana?

Hiki i ka hapa nui o nā mea maʻi ke kalaiwa iā lākou iho i ka home ma hope o ka loaʻa ʻana o kēia hoʻokomo ʻana, no ka mea, ʻaʻole ia e hoʻoulu i ka hiamoe a i ʻole e hoʻopilikia i kou hiki ke hoʻokele i kahi kaʻa. Akā, inā ʻoe e ʻike i ka ʻūlū, ka luhi, a i ʻole nā ​​hōʻailona ʻē aʻe e pili ana i kāu kalaiwa ʻana, ʻoi aku ka maikaʻi e hoʻonohonoho i kekahi e kalaiwa iā ʻoe i ka home.

Q3: Ehia mau manawa e pono ai iaʻu kēia mau hoʻokomo ʻana?

Aia ka pinepine o nā hoʻokomo ʻana i kāu kūlana kikoʻī a me ka hoʻolālā lapaʻau. Loaʻa i kekahi poʻe maʻi nā hoʻokomo ʻana i kēlā me kēia pule no kekahi mau pule, a ʻo nā mea ʻē aʻe paha e loaʻa iā lākou i ka liʻiliʻi. E wehewehe kāu oncologist i kāu papa manawa a me ke kumu e maikaʻi ai kēlā manawa no kou kūlana.

Q4: E nalowale anei koʻu lauoho mai kēia lapaʻau?

ʻAʻole he hopena ʻaoʻao maʻamau ka nalowale o ka lauoho o ka rituximab, ʻaʻole like me nā lāʻau chemotherapy kuʻuna. Mālama ka hapa nui o nā mea maʻi i ko lākou lauoho maʻamau i ka wā o ka lapaʻau. Inā ʻoe e ʻike i nā loli i kou lauoho, ʻoi aku ka pili ʻana i nā lāʻau lapaʻau ʻē aʻe āu e lawe nei a i ʻole ke koʻikoʻi o kou kūlana ma lalo.

Q5: Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e loaʻa ai kēia lapaʻau?

Pono ʻoe e pale i nā lāʻau lapaʻau ola i ka wā e loaʻa ai ka rituximab a no kekahi mau mahina ma hope o ka pau ʻana o ka lapaʻau. Akā, hiki i kāu kauka ke ʻōlelo i kekahi mau lāʻau lapaʻau i hoʻopau ʻia, e like me ka pana flu, e kōkua iā ʻoe e pale iā ʻoe i ka wā e hoʻopau ʻia ai kāu ʻōnaehana pale. E kūkākūkā mau i nā lāʻau lapaʻau me kāu hui mālama ola ma mua o ka loaʻa ʻana iā lākou.